Skip to main navigation Skip to search Skip to main content

SBIR: Phase II: Flow responsive embolic agent for the complete devascularization of meningiomas

Project: Research

Project Details

StatusFinished
Effective start/end date10/28/2104/30/23

Funding

  • National Cancer Institute: $383,579.00